These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6443775)

  • 1. Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
    Heimbach DM
    Rev Infect Dis; 1984; 6 Suppl 3():S744-50. PubMed ID: 6443775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin.
    Elder HA; Roy I
    Rev Infect Dis; 1984; 6 Suppl 3():S734-43. PubMed ID: 6443774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
    Caplan DB; Buchanan CN
    Rev Infect Dis; 1984; 6 Suppl 3():S705-10. PubMed ID: 6443771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of skin and soft-tissue infections with cefsulodin.
    Mogabgab WJ
    Rev Infect Dis; 1984; 6 Suppl 3():S721-7. PubMed ID: 6400534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
    van der Meer JW; Matze-van der Lans A; Mattie H
    Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
    Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Graham IE; Ibraham MZ
    Urology; 1986 Nov; 28(5):446-50. PubMed ID: 3787915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
    Chandrasekar PH; Crane LR; Bailey EJ
    J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia.
    Nichols L; Gudmundsson S; Maki DG
    Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa.
    Pottage JC; Karakusis PH; Trenholme GM
    Rev Infect Dis; 1984; 6 Suppl 3():S728-33. PubMed ID: 6443773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefsulodin treatment for serious Pseudomonas aeruginosa infections.
    Routman A; Van Manen W; Haddad R; Pollock B; Holmes B; Mogabgab WJ
    J Int Med Res; 1986; 14(5):242-53. PubMed ID: 3770290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns.
    Cooper RA; Halas E; Molan PC
    J Burn Care Rehabil; 2002; 23(6):366-70. PubMed ID: 12432313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacokinetic study of parenteral administration of cefsulodin in pediatric patients in Japan.
    Nishimura T; Fujii R
    Rev Infect Dis; 1984; 6 Suppl 3():S751-8. PubMed ID: 6571339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas infections in Tohid Burn Center, Iran.
    Rastegar Lari A; Bahrami Honar H; Alaghehbandan R
    Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
    Sanders WE; Sanders CC
    J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of superinfections caused by pyocyanic bacillus in patients with mucoviscidosis. Efficacy of cefsulodin in combination with an aminoglycoside].
    Jehanne M
    Pathol Biol (Paris); 1989 May; 37(5):500-3. PubMed ID: 2780107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
    Ullah F; Malik SA; Ahmed J
    Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
    Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S
    Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-thickness porcine burns infected with Staphylococcus aureus or Pseudomonas aeruginosa can be effectively treated with topical antibiotics.
    Tsai DM; Tracy LE; Lee CC; Hackl F; Kiwanuka E; Minasian RA; Onderdonk A; Junker JP; Eriksson E; Caterson EJ
    Wound Repair Regen; 2016 Mar; 24(2):356-65. PubMed ID: 26800421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.